This announcement is a separate document:
開拓藥業-B：2022年度報告及2023中期報告補充公告
KINTOR PHARMA-B: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE 2022 ANNUAL REPORT AND THE 2023 INTERIM REPORT
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.